Browse treatments

…nt predictors of renal IRAEs. As for dermatological IRAEs, only Chemotherapy (p = 0.031) and cancer stage (p=0.006) were significant predict…

… a leading cause of cancer-related mortality globally. Although chemotherapy and targeted therapies provide clinical benefits, their efficac…

…rent treatments including surgery, radiation, chemotherapy, and immunotherapy provide limited efficacy.2 Mesothelin (MSLN) is a tumor-associa…

…sentation. While immune checkpoint blockade (ICB) combined with chemotherapy provides limited benefits, most patients do not achieve durable…

…imodal conventional therapies such as surgery, radiotherapy and chemotherapy have shown limited results in glioma patients. Over the last de…

…ing the interaction between compromised DNA damage response and chemotherapy sensitivity.Conclusions In the myCare-040 cohort, most aberrati…

…ld tumors, where conventional checkpoint inhibitors often fail. Chemotherapy, particularly agents like Docetaxel, can induce immunogenic cel…

…sponse (pCR) at the time of definitive surgery who had received chemotherapy along with Pembrolizumab as neoadjuvant settings. After the def…

…ble clinical outcomes for stage II/III NSCLC patients underwent neoadjuvant immunotherapy. Vβ24-1Jβ2-1 and Vβ29-1Jβ2-7 were mainly localized in non-exhau…

…ceived a more effective (and less expensive) treatment, such as chemotherapy, if their ‘non-response’ status could have been predicted at ba…

… who had relapsed after 2 prior treatments which had prior ICI, Chemotherapy and Docetaxel. Eligible patients must have histologically confi…

… has been updated to immune checkpoint inhibitors combined with chemotherapy. However, immuno-chemotherapy for BTC still demonstrates signif…